http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-062773-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_408a673e5f3674e77d63dfe2a7856215 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1841 |
| filingDate | 2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-062773-A1 |
| titleOfInvention | TGF BETA MONOMEROS AND MEDICINES |
| abstract | The use of monomeric TGF-betas (transforming growth factors) or their fragments or derivatives, as medicaments, is disclosed. These medicaments preferably comprise monomeric TGF-beta3 or fragments or derivatives thereof. The medications disclosed can be used in the acceleration of wounds and / or the inhibition of scar generation, in the promotion of epithelial regeneration or in the prevention and / or treatment of fibrotic disorders. Claim 1: A TGF-beta monomer, or a biologically active fragment or derivative thereof, for use as a medicament. |
| priorityDate | 2006-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.